COVID-19 Outbreak and Oncological Surgery Practice
- PDF / 172,246 Bytes
- 3 Pages / 595.276 x 790.866 pts Page_size
- 110 Downloads / 206 Views
ORIGINAL ARTICLE
COVID-19 Outbreak and Oncological Surgery Practice Merve Tokocin 1 & Talar Vartanoglu Aktokmakyan 1
&
Yuksel Altinel 1 & Ahmet Akbas 1
Received: 1 June 2020 / Accepted: 21 September 2020 # Indian Association of Surgical Oncology 2020
Abstract The emergence of COVID-19 has caused a global public health emergency. With the World Health Organization (WHO) reporting the novel coronavirus outbreak a pandemic, the focus is needed on the influence of this rapidly spreading viral infection on cancer patients. In this study, we aimed to address cancer-related operations during the COVID-19 outbreak. We retrospectively reviewed 26 patients who had undergone cancer surgeries admitted from March 13 to May 13, 2020, during the COVID-19 epidemic at Istanbul Bagcilar Training and Research Hospital, as a pandemic hospital. A total of 26 cases of COVID-19 were enrolled in the study. Seventeen (65%) were female, and 9 (35%) were male. The mean age was 52.4 (range 28–74). The mean body mass index (BMI) is 27.8 kg/m2 (range 17.6–34.0). Eight of them had comorbidities. 7 patients needed an intensive care unit (ICU). Only one patient was COVID-19 positive in the PCR test, while the others were negative. In addition to this patient, 3 other patients were COVID-19 positive on computed tomography (CT). The patients included in this study underwent various oncologic surgery procedures. While 24 patients were discharged without any problems, 2 patients developed complications. Due to respiratory problems, the patient could not get out of intensive care and died on the sixth postoperative day. It is the obligation of the institutions and the medical staff to reassure patients by creating safe postoperative surgical environments free of COVID-19. Surgeon leaders need to synthesize actual data to make the best decisions for their cancer patients. Keywords Cancer . Cancer surgery . COVID-19
Introduction The emergence of COVID-19 has caused a global public health emergency. The virus was named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has a phylogenetic similarity to SARS-CoV-1 that caused the SARS pandemic in 2002 [1]. According to the World Health Organization (WHO), as of 10 a.m. CEST 20 May 2020, 4,789,205 people were infected while 318,789 people have died so far [2]. With the World Health Organization (WHO) reporting the novel coronavirus outbreak a pandemic, the focus is needed on the influence of this rapidly spreading viral infection on cancer patients [3, 4]. Patients with cancer are more susceptible to infection than are individuals without cancer because of malignancy and anticancer therapy result in an immunosuppressive situation [5]. Limited studies and
* Talar Vartanoglu Aktokmakyan [email protected] 1
Istanbul Bagcilar Training And Research Hospital, Merkez Mah, 34200 Istanbul, Turkey
researches respecting the readiness program for cancer patients during an infectious pandemic exist. In this study, we aimed to address cancer-related operations during the COVID-19 outbreak.
Material
Data Loading...
